Investigator

Julie Anna Wolfson

Associate Professor (with tenure) · University of Alabama at Birmingham, Pediatric Hematology-Oncology, Institute for Cancer Outcomes and Survivorship

JAWJulie Anna Wolfson
Papers(1)
Fertility Preservatio…
Collaborators(10)
Karly MurphyLingyun JiMelissa P. BeaucheminMichael E. RothSubhash RamakrishnanSusan K. ParsonsAaron J. SugalskiCarol KittelChandylen L. Nighting…David R. Freyer
Institutions(10)
University Of Alabama…East Carolina Univers…University of Souther…Columbia University I…University of Texas M…Childrens Oncology Gr…Tufts Medical CenterThe University Of Tex…Wake Forest UniversityUsc Norris Comprehens…

Papers

Fertility Preservation Services for Adolescents and Young Adults: 2022 National Cancer Institute Community Oncology Research Program Landscape Assessment

PURPOSE Given the impact of cancer treatment on fertility among adolescents and young adults (AYAs: 15-39 years), it is important to ensure AYAs access to fertility preservation (FP). However, the availability of FP services for AYAs treated in community settings is unknown. We examined FP access at National Cancer Institute Community Oncology Research Program (NCORP) practice groups. METHODS The 2022 NCORP Landscape Assessment survey captured available resources and cancer care services including FP services at practice groups. We described FP services as accessible (on-site or off-site) versus not accessible by AYA-treating status (as previously defined). Univariable and multivariable analyses were used to evaluate associations between FP services and practice characteristics (NCORP classification [minority/underserved or community] and proportion of Medicaid or uninsured above/below the national average). RESULTS Among 271 practice groups responding to the survey, 100 were categorized as AYA-treating, of which 32% had neither male nor female FP services available. Sperm banking was available at 59 AYA-treating practices, among which 43 (73%) referred for sperm banking off-site. Although approximately half of AYA-treating practices reported accessible female FP services (embryo = 54%, oocyte = 55%, ovarian tissue = 40%), most of them referred patients off-site (embryo = 72%, oocyte = 80%, ovarian tissue = 83%). The odds of access to male FP were lower at minority/underserved practices (odds ratio, 0.34 [95% CI, 0.13 to 0.88]; P = .026; ref = community); however, this same relationship was not seen for females. CONCLUSION Despite guidelines surrounding FP discussions before cancer therapy, and strong consensus regarding the importance of FP access, many AYA-treating practices in community settings lack access to FP services. Understanding how to leverage available services and broadly expand access is urgently needed to facilitate guideline-concordant, high-quality cancer care for AYAs.

92Works
1Papers
13Collaborators
NeoplasmsCancer Care FacilitiesReinfectionHematologic NeoplasmsDown SyndromeChronic Disease

Positions

2024–

Associate Professor (with tenure)

University of Alabama at Birmingham · Pediatric Hematology-Oncology, Institute for Cancer Outcomes and Survivorship

2021–

Associate Professor (tenure track)

The University of Alabama at Birmingham · Pediatric Hematology-Oncology, Institute for Cancer Outcomes and Survivorship

2015–

Assistant Professor (tenure track)

The University of Alabama at Birmingham · Pediatrics / Institute for Cancer Outcomes and Survivorship

2012–

Assistant Professor

City of Hope Comprehensive Cancer Center · Population Sciences

2011–

Assistant Professor

City of Hope Comprehensive Cancer Center · Pediatrics

2010–

Staff Physician

City of Hope Comprehensive Cancer Center · Pediatrics

1998–

Substitute Teacher

Gulliver Schools

1994–

Instructor

Caledonian School · English as a Second Language

1994–

Lecturer

Právnická Fakulta Univerzita Karlova v Praze · English as a Second Language, First Certificate Class

Education

2009

MSHS

UCLA School of Public Health · Health Services

2009

Fellowship

Children's Hospital Los Angeles Department of Pediatrics · Division of Pediatric Hematology-Oncology

2005

Pediatrics Residency

Massachusetts General Hospital · Pediatrics

2002

M.D.

University of Florida College of Medicine

1994

A.B.

Harvard College · English and American Literature and Language